[HTML][HTML] Antimicrobial activity of α-peptide/β-peptoid lysine-based peptidomimetics against colistin-resistant pseudomonas aeruginosa isolated from cystic fibrosis …
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial Activity of alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen, N Hoiby… - Frontiers in …, 2019 - hero.epa.gov
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen… - Frontiers in …, 2019 - research.regionh.dk
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen, N Høiby… - 2019 - agris.fao.org
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial activity of α-peptide/β-peptoid lysine-based peptidomimetics against colistin-resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients.
N Molchanova, WHZ Wang HengZhuang, PR Hansen… - 2019 - cabidigitallibrary.org
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen… - Frontiers in …, 2019 - europepmc.org
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
[HTML][HTML] Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic …
N Molchanova, H Wang, PR Hansen, N Høiby… - Frontiers in …, 2019 - frontiersin.org
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
[引用][C] Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis …
N Molchanova, H Wang, PR Hansen, N Høiby… - Frontiers in …, 2019 - cir.nii.ac.jp
Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant
Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients | CiNii Research CiNii 国立 …
Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients | CiNii Research CiNii 国立 …
[HTML][HTML] Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic …
N Molchanova, H Wang, PR Hansen… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …